Research Progress of Related Laboratory Testing Indexes before and after Mother-Infant Blocking in HIV/AIDS Pregnant Women ()
Affiliation(s)
1Department of Clinical laboratory, Guigang Hospital of Integrated Traditional Chinese and Western Medicine, Guigang Red Cross Hospital, Guiyang, China.
2Department of Osteoarthritis, Guigang Hospital of Integrated Traditional Chinese and Western Medicine, Guigang Red Cross Hospital, Guiyang, China.
3Department of Clinical laboratory, The Fourth People’s Hospital Nanning Guangxi, Guangxi Medical University Affiliated to Infectious Diseases Hospital of Nanning, Guangxi AIDS Clinical Treatment Center (Nanning), Nanning, China.
ABSTRACT
More than 90% of HIV-positive
children come from mother-to-child transmission, so mother-to-child
interdiction is the main measure to prevent AIDS in children. Relevant data
show that the incidence of mother-to-child transmission of HIV usually fluctuates
between 15% and 50% without intervention. Standardized and effective
comprehensive intervention can reduce the transmission rate of mother to child
to less than 1%. At present, it is believed that mother-to-child transmission
of AIDS can be blocked by comprehensive intervention, and its mechanism has
been clearly studied. Combined with highly effective antiviral treatment, safe
labor and artificial feeding, the mother to child transmission rate can be
reduced to less than 1%. However, due to the effect of drugs on mother-to-child
transmission of AIDS may lead to some changes in the main biochemical
indicators of mother-to-child, there is no systematic analysis of the viral
load, T lymphocyte subsets and major biochemical indicators of HIV/AIDS pregnant
women before and after maternal-to-child transmission. In this study, the viral
load, T lymphocyte subsets and major biochemical indicators of HIV/AIDS
pregnant women before and after maternal-infant blockade were dynamically
analyzed. It is hoped that this study will help to observe the basic physical
fitness and disease development of pregnant women with HIV/AIDS during
pregnancy, to provide a strong basis for the treatment and evaluation of
maternal-infant blockade of HIV/AIDS pregnant women, and to establish a
complete set of laboratory indicators to understand the body status of pregnant
women at all stages to minimize
the probability of fetal transmission, which will make good economic and social
benefits.
Share and Cite:
Su, G. , Qin, L. and Mo, L. (2020) Research Progress of Related Laboratory Testing Indexes before and after Mother-Infant Blocking in HIV/AIDS Pregnant Women.
World Journal of AIDS,
10, 149-157. doi:
10.4236/wja.2020.102013.
Cited by
No relevant information.